Treatment experiences for skin and soft tissue infections among participants of syringe service programs in North Carolina

Public Deposited
Analytics

Downloadable Content

Download PDF
Request Version for Screen Reader
Creator
  • Figgatt, Mary
    • Affiliation: Injury Prevention Research Center
  • Salazar, Zach
    • Other Affiliation: North Carolina Survivors Union
  • Vincent, Louise
    • Other Affiliation: North Carolina Survivors Union
  • Carden-Glenn, Diannee
    • Other Affiliation: ekiM for Change
  • Link, Kelly
    • Other Affiliation: Community Hope Alliance
  • Kestner, Lauren
    • Other Affiliation: Center for Prevention Services
  • Yates, Tyler
    • Other Affiliation: Guilford County Solution to the Opioid Problem
  • Schranz, Asher
    • Affiliation: School of Medicine, Department of Medicine
  • Joniak-Grant, Elizabeth
    • Affiliation: Injury Prevention Research Center
  • Dasgupta, Nabarun
    • Affiliation: Injury Prevention Research Center
Abstract
  • Introduction: Bacterial and fungal infections, such as skin and soft tissue infections (SSTIs) and infective endocarditis (IE), are increasing among people who use drugs in the United States. Traditional healthcare settings can be inaccessible and unwelcoming to people who use drugs, leading to delays in getting necessary care. The objective of this study was to examine SSTI treatment experiences among people utilizing services from syringe services programs. This study was initiated by people with lived experience of drug use to improve quality of care. Methods: We conducted a cross-sectional survey among participants of five syringe services programs in North Carolina from July through September 2020. Surveys collected information on each participant’s history of SSTIs and IE, drug use and healthcare access characteristics, and SSTI treatment experiences. We examined participant characteristics using counts and percentages. We also examined associations between participant characteristics and SSTI history using binomial linear regression models. Results: Overall, 46% of participants reported an SSTI in the previous 12 months and 10% reported having IE in the previous 12 months. Those with a doctor they trusted with drug use-related concerns had 27 fewer (95% confidence interval = − 51.8, − 2.1) SSTIs per every 100 participants compared to those without a trusted doctor. Most participants with a SSTI history reported delaying (98%) or not seeking treatment (72%) for their infections. Concerns surrounding judgment or mistreatment by medical staff and self-treating the infection were common reasons for delaying or not seeking care. 13% of participants used antibiotics obtained from sources other than a medical provider to treat their most recent SSTI. Many participants suggested increased access to free antibiotics and on-site clinical care based at syringe service programs to improve treatment for SSTIs. Conclusions: Many participants had delayed or not received care for SSTIs due to poor healthcare experiences. However, having a trusted doctor was associated with fewer people with SSTIs. Improved access to non-judgmental healthcare for people who use drugs with SSTIs is needed. Expansion of syringe services program-based SSTI prevention and treatment programs is likely a necessary approach to improve outcomes among those with SSTI and IE.
Date of publication
DOI
Related resource URL
Resource type
  • Article
Rights statement
  • In Copyright
Language
  • English

Relations

Parents:

This work has no parents.

In Collection:

Items

Thumbnail Title Date Uploaded Visibility Actions
file details PubMedID-8324443.pdf 2022-09-26 Public Download